USE OF RECOMBINANT ALFA-2B INTERFERON IN A CHRONIC HEPATITIS-C CONTROLLED TRIAL

被引：0
|
作者：
ARUS, E [1 ]
INFANTE, M [1 ]
PADRON, G [1 ]
FERNANDEZ, A [1 ]
ROCA, J [1 ]
MORALES, M [1 ]
GRA, B [1 ]
机构：
[1] HOSP LUIS DIAZ SOTO,CTR GENET ENGN & BIOTECHNOL,INST GASTROENTEROL,HAVANA,CUBA
来源：
HEPATOLOGY | 1994年 / 19卷 / 04期
关键词：
D O I：
10.1016/0270-9139(94)90328-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：I40 / I40
页数：1
相关论文
共 50 条
  • [41] TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH RECOMBINANT INTERFERON ALFA-2B
    NIEDERLE, N
    KLOKE, O
    MAY, D
    BECHER, R
    OSIEKA, R
    SCHMIDT, CG
    INVESTIGATIONAL NEW DRUGS, 1987, 5 : S19 - S25
  • [42] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    Rao, P. N.
    Koshy, Abraham
    Philip, Jacob
    Premaletha, Narayanan
    Varghese, Joy
    Narayanasamy, Krishnasamy
    Mohindra, Samir
    Pai, Nitin Vikas
    Agarwal, Manoj Kumar
    Konar, Ashoknanda
    Vora, Hasmukh B.
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 520 - 526
  • [43] Favorable pharmacokinetics of albumin interferon alfa-2b in subjects with chronic hepatitis C
    Fiscella, Michele
    Balan, Vijayan
    Nelson, David
    Bain, Vincent
    Zeuzem, Stefan
    McHutchison, John
    Freimuth, William
    Subramanian, Mani
    Corey, Alfred
    HEPATOLOGY, 2006, 44 (04) : 613A - 614A
  • [44] Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: A randomized multicenter trial
    Lindsay, KL
    Davis, GL
    Schiff, ER
    Bodenheimer, HC
    Balart, LA
    Dienstag, JL
    Perrillo, RP
    Tamburro, CH
    Goff, JS
    Everson, GT
    Silva, M
    Katkov, WN
    Goodman, Z
    Lau, JYN
    Maertens, G
    Gogate, J
    Sanghvi, B
    Albrecht, J
    Milstein, S
    Kniffen, J
    Roach, K
    Brodeur, C
    Regenstein, F
    Taylor, B
    DeMelia, HC
    Bodicky, C
    Miller, BL
    Danhour, G
    Bariletto, S
    HEPATOLOGY, 1996, 24 (05) : 1034 - 1040
  • [45] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    PN Rao
    Abraham Koshy
    Jacob Philip
    Narayanan Premaletha
    Joy Varghese
    Krishnasamy Narayanasamy
    Samir Mohindra
    Nitin Vikas Pai
    Manoj Kumar Agarwal
    Ashokna Konar
    Hasmukh B Vora
    World Journal of Hepatology, 2014, (07) : 520 - 526
  • [46] THE USE OF RECOMBINANT INTERFERON ALFA-2B IN ELDERLY PATIENTS WITH ANTI-HCV-POSITIVE CHRONIC ACTIVE HEPATITIS
    BRESCI, G
    DELCORSO, L
    ROMANELLI, AM
    GIULIANO, G
    PENTIMONE, F
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1993, 41 (08) : 857 - 862
  • [47] A RANDOMIZED CONTROLLED TRIAL OF RECOMBINANT INTERFERON-ALPHA IN CHRONIC HEPATITIS-C IN HEMOPHILIACS
    MAKRIS, M
    PRESTON, FE
    TRIGER, DR
    UNDERWOOD, JCE
    WESTLAKE, L
    ADELMAN, MI
    BLOOD, 1991, 78 (07) : 1672 - 1677
  • [48] RECOMBINANT INTERFERON-ALFA THERAPY FOR CHRONIC HEPATITIS-C - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    DIBISCEGLIE, AM
    MARTIN, P
    KASSIANIDES, C
    LISKERMELMAN, M
    MURRAY, L
    WAGGONER, J
    GOODMAN, Z
    BANKS, SM
    HOOFNAGLE, JH
    NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22): : 1506 - 1510
  • [49] A RANDOMIZED, CONTROLLED TRIAL OF INTERFERON ALFA-2B ALONE AND AFTER PREDNISONE WITHDRAWAL FOR THE TREATMENT OF CHRONIC HEPATITIS-B
    PERRILLO, RP
    SCHIFF, ER
    DAVIS, GL
    BODENHEIMER, HC
    LINDSAY, K
    PAYNE, J
    DIENSTAG, JL
    OBRIEN, C
    TAMBURRO, C
    JACOBSON, IM
    SAMPLINER, R
    FEIT, D
    LEFKOWITCH, J
    KUHNS, M
    MESCHIEVITZ, C
    SANGHVI, B
    ALBRECHT, J
    GIBAS, A
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (05): : 295 - 301
  • [50] Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C
    Wong, JB
    Davis, GL
    Pauker, SG
    AMERICAN JOURNAL OF MEDICINE, 2000, 108 (05): : 366 - 373
12345